Krónikus vesebetegség: vizsgálatok itt: Izrael
9 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Where
- Afula, Ashdod, Be’er Ya‘aqov, Haifa, Jerusalem, Kfar Saba, Nahariya, Petah Tikva, Rehovot, Tel Aviv, Tiberias
- Életkor
- 18 év and over
- People
- 5000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00 - 3. fázisTaking peopleA Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- Where
- Ashdod, Ashkelon, Beersheba, Haifa, Jerusalem, Kfar Saba, Nahariya, Petah Tikva, Ramat Gan, Rehovot, Safed, Sakhnin, Tel Aviv, Tsrifin
- Életkor
- 50 év and over
- People
- 7140 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00 - No phaseCsak meghívásosAssessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
- Where
- Haifa
- Életkor
- 0 Minutes to 2 hét
- People
- 8000 worldwide
- Run by
- Indiana University
See details and how to joinNCT06823115 - 2. fázisTaking peopleSafety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus
- Where
- Jerusalem, Petah Tikva
- Életkor
- 12 év to 18 év
- People
- 18 worldwide
- Run by
- Vifor Fresenius Medical Care Renal Pharma
See details and how to joinNCT06593392 · EU 2023-509909-74-00 - 3. fázisTaking peopleA Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- Where
- Ashkelon, Jerusalem, Petah Tikva
- Életkor
- 18 év to 100 év
- People
- 540 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00 - 3. fázisTaking peopleA Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
- Where
- Beersheba, Jerusalem, Nahariya, Petah Tikva, Tel Aviv
- Életkor
- 1 év to 18 év
- People
- 100 worldwide
- Run by
- Bayer
See details and how to joinNCT05457283 · EU 2023-504885-50-00 - 2/3. fázisTaking peopleCombined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Where
- Afula, Ashkelon, Haifa, Holon, Nahariya, Petah Tikva, Ramat Gan, Rehovot, Safed, Tel Aviv, Tiberias
- Életkor
- 18 év and over
- People
- 3110 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00 - 3. fázisTaking peopleA Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
- Where
- Ashkelon, Be’er Ya‘aqov, Hadera, Haifa, Holon, Kfar Saba, Nahariya, Ramat Gan, Rehovot, Tiberias
- Életkor
- 18 év and over
- People
- 7000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07753993 · EU 2025-523994-41-00 - No phaseTaking peoplePragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)
- Where
- Jerusalem, Kfar Saba, Ramat Gan, Tel Aviv
- Életkor
- 18 év and over
- People
- 3600 worldwide
- Run by
- The University of Queensland
See details and how to joinNCT03573089